Apellis Pharmaceuticals (APLS) FY 2025 Conference June 11, 2025 10:40 AM ET Speaker0 Good morning, everyone. Thank you so much for joining us. I'm Salveen Richter, Biotechnology Analyst at Goldman Sachs, and I'm really pleased to have with us today the Apellis team. Sitting next to me is Cedric Francois, CEO, Co Founder and President. Next to him is David Achleson, Head of Global Commercial and then Tim Sullivan, CFO. To start here, before we dive into specifics, can you just provide us a snapshot of your b ...

Apellis Pharmaceuticals (APLS) 2025 Conference May 27, 2025 02:30 PM ET Speaker0 Hey, good afternoon, everyone. I'm happy to have Appellis as the next fireside chat. So we have Cedric Francois with us, CEO and Tim Sullivan, CFO. And recognizing that you are a broader C3 complement inhibitor company, I am stating the obvious that this is an ophthalmology conference. And so maybe we can just start out and level set and talk about your ophthalmology franchise, the commercial prospects, the pipeline pursuits an ...